Effects of 5,5'-diphenylhydantoin on the metabolic pathway of thyroid hormone in rats

European Journal of Endocrinology

Volumn 136, Issue 3, 1997, Pages 324-329

  Schröder Van Der Elst, Janny P ^a,b   Van Der Heide, Daan ^b   DiStefano III, Joe J ^c   Van Der Bent, Chris ^a   Kaptein, Ellen ^d   Visser, Theo J ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; PHENYTOIN; THYROID HORMONE; THYROXINE;

ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; HORMONE RELEASE; ISOTOPE LABELING; MALE; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

EID: 1842291523     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360324     Document Type: Article

References (30)

1. Curran PG & DeGroot LJ. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocrine Reviews 1991 12 135-150.
2. Smith PJ & Surks MI. Multiple effects of 5,5′-diphenylhydantoin on the thyroid hormone system. Endocrine Reviews 1984 5 514-524.
3. Larsen PR, Atkinson AJ Jr, Wellman HN & Goldsmith RE. The effect of diphenylhydantoin on thyroxine metabolism in man. Journal of Clinical Investigation 1970 49 1266-1279.
4. 131I in the rat. Endocrinology 1966 79 106-118.
5. Faber J, Lumholtz IB, Kirkegaard C, Poulsen S, Holme Jorgensen P, Siersbaek-Nielsen K et al. The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3,5,3′-triiodothyronine, 3,3′,5′-triiodothyronine and 3′,5′-diiodothyronine in man. Journal of Clinical Endocrinology and Metabolism 1985 61 1093-1096.
6. Schröder-van der Elst JP & Van der Heide D. Effects of 5,5′-diphenylhydantoin on thyroxine and 3,5,3′-triiodothyronine concentrations in several tissues of the rat. Endocrinology 1990 126 186-190.
7. DiStefano JJ, Jang M, Malone TK & Broutman M. Comprehensive kinetics of triiodothyronine production, distribution and metabolism in blood and tissue pools of the rat using optimized blood-sampling protocols. Endocrinology 1982 110 198-202.
8. DiStefano JJ, Malone TK & Jang M. Comprehensive kinetics of thyroxine distribution and metabolism in blood and tissue pools of the rat from only six blood samples: dominance of large, slowly exchanging tissue pools. Endocrinology 1982 111 108-117.
9. Schröder-van der Elst JP, van der Heide D, van der Bent C, Kaptein E, Visser TJ & DiStefano JJ III. Effects of 5,5′-diphenylhydantoin on the thyroid status in rats. European Journal of Endocrinology 1996 134 221-224.
10. De Herder WW. Enterohcpatic circulation of triiodothyronine. Thesis, Rotterdam, The Netherlands 1990.
11. DiStefano JJ, Sternlicht M & Harris DR. Rat enterohepatic circulation and intestinal distribution of enterally infused thyroid hormones. Endocrinology 1988 123 2526-2539.
12. DiStefano JJ, Nguyen TT & Yen YM. Sites and patterns of absorption of 3,5,3′-triiodothyronine and thyroxine along rat small and large intestines. Endocrinology 1992 131 275-280.
13. 4 by rat intestinal bacteria. American Journal of Physiology, Endocrinology and Metabolism 1993 264 966-972.
14. Ad hoc Committee on Standards for Nutritional Studies. Report of the American Institute of Nutrition. Journal of Nutrition 1977 7 1340-1348.
15. Marino A, DiStefano JJ & Landaw EM. DIMSUM: an expert system for multiexponential model discrimination. American Journal of Physiology, Endocrinology and Metabolism 1992 262 546-556.
16. Lindell R, DiStefano JJ & Landaw EM. Statistical variability of parameter bounds for n-pool unidentifiable mammillary and catenary compartmental models. Mathematical Biosciences 1988 91 175-199.
17. McFarlane AS. Catabolism of plasma-proteins. Lancet 1963 i 131.
18. Beetstra JB, van Engelen JGM, Karels P, van der Hoek HJ, de Jong M, Docter R et al. Thyroxine and 3,3′,5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology 1991 28 741-746.
19. Janssen PLTMK, Van der Heide D, Visser TJ, Kaptein E & Beynen AC. Thyroid function and deiodinase activity in rats with marginal iodine deficiency. Biology Trace Elements Research 1994 40 237-246.
20. 3 in the plasma of rats during the first 3 months of life. Acta Endocrinologica 1980 93 448-454.
21. Mendel CM, Laughton CW, McMahon FA & Cavalieri RR. Inability to detect an inhibitor of thyroxine-serum protein binding in sera from patients with non-thyroidal illness. Metabolism 1991 40 491-502.
22. Woodbury DM 1982 Phenytoin: mechanism of action. In Antiepileptic Drugs, pp 448-454. Eds DM Woodbury et al. New York: Raven Press, 1982.
23. D'Arcangelo D, Silletta MG, Di-Francesco AL, Bonfitto N, Di-Cerbo A, Falasca M et al. Physiological concentrations of thyrotropin increase cytosolic calcium levels in primary cultures of human thyroid cells. Journal of Clinical Endocrinology and Metabolism 1995 80 1136-1143.
24. Bacharach T & Evans JR. Enlargement of colon secondary to hypothyroidism. Annals of Internal Medicine 1957 47 121-124.
25. Baker JT & Harvey RF. Bowel habits in thyrotoxicosis and hypothyroidism. British Medical Journal 1971 322-323.
26. Van Doorn J, Van der Heide D & Roelfsema F. Sources and quantity of 3,5,3′-triiodothyronine in several tissues of the rat. Journal of Clinical Investigation 1983 72 1778-1792.
27. Galton VA, McCarthy PT & St Germain DL. The ontogeny of iodothyronine deiodinase systems in liver and intestine of the rat. Endocrinology 1991 128 1717-1722.
28. Woodbury DM. Phenytoin: absorption, distribution and excretion. In Antiepileptic Drugs, pp 269-281. Eds DM Woodbury et al. New York: Raven Press, 1982.
29. Van der Heide D, Schreurs M, van Snik G, Schröder-van der Elst JP, van der Bent C & Van Oosten DJ. Influence of thyroid status on total body oxygen consumption and enzyme activities. Thyroid 1992 2 (Suppl 1) s-62.
30. Visser TJ, Kaptein E, Van Toor H, Van Raaij JAGM, Van der Berg KJ & Tjong Tjin Joe C. Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions. Endocrinology 1993 133 2177-2186.